Viralytics: Viralytics takeover gets FIRB approval
23 May 2018 - The takeover of Viralytics (ASX:VLA) by global pharmaceutical giant, Merck has come one step closer with Merck getting the green light from the Foreign Investment Review Board.
Read full article »
Viralytics focuses on the development of oncolytic immunotherapies for the treatment of cancer.
Read more